Goldman Sachs’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,048,297
Closed -$18.4M 4661
2019
Q4
$18.4M Sell
3,048,297
-3,133,885
-51% -$18.9M ﹤0.01% 1673
2019
Q3
$22.3M Sell
6,182,182
-356,043
-5% -$1.28M 0.01% 1449
2019
Q2
$17.5M Sell
6,538,225
-584,416
-8% -$1.57M 0.01% 1661
2019
Q1
$21.1M Buy
7,122,641
+1,733,840
+32% +$5.13M 0.01% 1578
2018
Q4
$8.57M Buy
5,388,801
+713,201
+15% +$1.13M ﹤0.01% 2002
2018
Q3
$17.2M Sell
4,675,600
-468,343
-9% -$1.72M ﹤0.01% 1729
2018
Q2
$14.6M Sell
5,143,943
-548,454
-10% -$1.55M ﹤0.01% 1810
2018
Q1
$21.1M Buy
5,692,397
+2,690,283
+90% +$9.98M 0.01% 1552
2017
Q4
$8.65M Buy
3,002,114
+295,376
+11% +$851K ﹤0.01% 1987
2017
Q3
$12.2M Sell
2,706,738
-906,956
-25% -$4.07M ﹤0.01% 1873
2017
Q2
$16.6M Sell
3,613,694
-111,973
-3% -$514K ﹤0.01% 1656
2017
Q1
$15.7M Sell
3,725,667
-726,375
-16% -$3.06M ﹤0.01% 1635
2016
Q4
$18.4M Sell
4,452,042
-1,047,198
-19% -$4.32M 0.01% 1527
2016
Q3
$44.5M Buy
5,499,240
+1,520,505
+38% +$12.3M 0.01% 1044
2016
Q2
$31M Buy
3,978,735
+1,388,241
+54% +$10.8M 0.01% 1156
2016
Q1
$20M Sell
2,590,494
-37,954
-1% -$293K 0.01% 1369
2015
Q4
$28.4M Buy
2,628,448
+358,020
+16% +$3.86M 0.01% 1169
2015
Q3
$15.7M Sell
2,270,428
-254,816
-10% -$1.76M 0.01% 1406
2015
Q2
$22.4M Sell
2,525,244
-635,363
-20% -$5.63M 0.01% 1289
2015
Q1
$31.2M Sell
3,160,607
-2,105,133
-40% -$20.8M 0.01% 1111
2014
Q4
$64.5M Buy
5,265,740
+1,652,636
+46% +$20.2M 0.02% 682
2014
Q3
$36.1M Buy
3,613,104
+948,742
+36% +$9.47M 0.01% 959
2014
Q2
$20.2M Buy
2,664,362
+254,230
+11% +$1.92M 0.01% 1258
2014
Q1
$7.93M Buy
2,410,132
+13,371
+0.6% +$44K ﹤0.01% 1714
2013
Q4
$7.96M Buy
2,396,761
+124,721
+5% +$414K ﹤0.01% 1707
2013
Q3
$6.86M Buy
2,272,040
+738,740
+48% +$2.23M ﹤0.01% 1705
2013
Q2
$12.5M Buy
+1,533,300
New +$12.5M ﹤0.01% 1262